Trial intelligence / Profile preview

Microdialysis validation for topical diclofenac delivery assessment

2006-001784-35Phase 4Completed

Sponsor
Miravo Healthcare
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of diclofenac and Dimethyl sulfoxide in osteoarthritis (OA), sponsored by Miravo Healthcare. Primary endpoints: Feasibility of microdialysis for local delivery assessment, Pharmacokinetics of diclofenac in subcutaneous tissue and plasma and 2 more. Started May 2006; status: completed.

02

Drugs

diclofenacDimethyl sulfoxide
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on 2006-001784-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001784-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call